Transglutaminase 3 (TGase 3), involved in the crosslinking of structural proteins in the epidermis, is activated by limited proteolysis of zymogen into two fragments during keratinocyte diŠerentiation. Using recombinant TGase 3, the N-terminus sequence of the proteolyzed fragment was analyzed. Antibody against the synthetic peptide corresponding to the cleavage site speciˆcally detected the fragment in the mouse forestomach extract.
Transglutaminase (TGase) is an enzyme that catalyzes the Ca 2＋ dependent cross-linking reaction between a g-carboxyamide group of glutamine and an e-amino group of lysine or other primary amine. 1, 2) To date, eight human TGase isozymes (Factor XIII, TGases 1-7) making up a large protein family have been found. 3) Among these isozymes, TGase 3 is involved in the formation of the corniˆed envelope in skin keratinocytes, where TGase functions to cross-link structural proteins such as involucrin, loricrin, and small proline-rich proteins during epidermal terminal diŠerentiation. 4) TGase 3 activation requires cleavage of a 77-kDa zymogen by an unknown protease to release two fragments of 47 and 30 kDa which then associate non-covalently to form the active enzyme. 5) Although proteases responsible for the proteolytic activation remain unknown, dispase, a protease from Bacillus polymyxa, is able to proteolyze the zymogen resulting in activation in vitro.
6,7) Dispase has been used for a tissue disaggregation procedure and accidentally found to cleave speciˆcally zymogen of TGase 3. It has been di‹cult to biochemically clarify the activation mechanisms of TGase 3 because the amounts of the proteolyzed TGase 3 are quite low in the epidermis.
In order to know the proteolytic activation mechanisms, it is crucial to determine the cleavage site of TGase 3 zymogen. The cleavage sites of human and mouse TGase 3 have been predicted based on the data for puriˆed guinea pig protein, but not directly identiˆed. 5) This study consists of three parts: (i) determination of the cleavage site, (ii) production of antibody speciˆc for the site and veriˆcation of its speciˆcity, and (iii) examination of cross-reactivity with an in vivo fragment.
First, recombinant proteins for human and mouse TGase 3 were puriˆed from baculovirus-infected insect cells and then digested with dispase ( Fig. 1A , left). The N-terminal amino acid sequences of 30-kDa fragments were determined by automated Edman degradation. As shown in Fig. 1B , the cleavage sites are situated before Phe-465 both in human and mouse TGase 3.
Next, we generated an antibody that speciˆcally recognized the cleavage site. Based on the determined amino acid sequence, a peptide (Phe-Gly-Ala-ThrSer) corresponding to the N-terminal amino acid sequence of the mouse 30-kDa fragment with an additional Cys residue at the C-terminus was synthesized. Then, the Cys residue of the peptide was covalently cross-linked with keyhole limpet hemocyanin (KLH) using m-maleimidobenzoil-N-hydroxysuccinimide ester, and used as the immunogen to raise antibody in rabbits. The antibody was a‹nity-puriˆed from antisera using a peptide-immobilized column. Further, in order to remove antibody that cross-reacted with TGase 3 zymogen, the antibody solution was passed through a gel immobilzing the acetylated peptide (Ac-Phe-Gly-Ala-Thr-Ser). The puriˆed antibody (anti-FGATS) predominantly reacted with the 30-kDa fragment, suggesting that it distinguishes the newly exposed N-terminal cleavage site generated by dispase-digestion from the sequence in the zymogen. (Fig. 1A, right) .
Then, in order to conˆrm the in vivo cleavage site, we examined whether the anti-FGATS antibody recognized the 30-kDa fragment in the mouse epithelial tissue. In mouse forestomach, where TGase 3 is expressed as in the case of skin and hair follicle, a A, Recombinant mouse TGase 3, puriˆed from baculovirus-infected insect cells, was digested with dispase. One mg of each protein before (lane 1) and after (lane 2) digestion was subjected to 10z SDS-PAGE, followed by CBB staining (left) and Western blotting using anti-FGATS antibody (right). The white, gray, and black arrows indicate the zymogen form, 47-kDa, and 30-kDa fragment, respectively. B, Cleavage sites of recombinant proteins for human and mouse TGase 3 proteolyzed by dispase. The amino acid sequence of the N-terminal sites for the 30-kDa fragments of both human and mouse TGase 3, generated by digestion with dispase, are indicated. The arrows before F indicate the cleavage site. The arrows in the dotted line indicate the cleavage sites that had been predicted based on the sequence of puriˆed guinea pig TGase 3.
5) The amino acid sequence in the box corresponds to the synthesized peptide. polyclonal antibody raised against TGase 3 zymogen detected both the zymogen and the proteolyzed forms ( Fig. 2A) . 8) However, probably due to instability, the amount of 30-kDa fragment was much lower than that of the 47-kDa fragment. In order to enrich these molecules in the extract, DEAE anion-exchange chromatography was performed. As shown in lane 2 of Fig. 2A, 30 -kDa fragment was detected in the partially puriˆed fraction. When the same sample was analyzed using anti-FGATS antibody, the 30-kDa fragment was apparently detected (Fig. 2B ).
In the partially puriˆed sample (lane 2), the band was clearer than that in the crude extract (lane 1). These results suggest that the in vivo cleavage site is at the N-terminal side of Phe-465.
In contrast to the estimated in vivo cleavage site by the immunological reaction with anti-FGATS antibody, Steinert et al. had predicted the putative cleavage site would be between Ser-469 and Ser-470 (arrows in dotted line in Fig. 1B ) both in human and mouse TGase 3. 5) To test the possibility of a secondary cleavage site, the antibody speciˆc to the Ser-Arg-Asn-Pro-Glu peptide was prepared in the same manner as that for producing anti-FGATS antibody. This antibody recognizes speciˆcally the N-terminus of the Ser-residue. However, no immunological-reaction was observed for the 30-kDa fragment both in the dispase-digested recombinant TGase 3 and also in the forestomach extract (data not shown).
In our recent report, human TGase 3 appeared to be located in the cytoplasm in the cultured keratinocytes and outer layer of the epidermis by immunohistochemical analysis using monoclonal antibody.
9)
The anti-FGATS antibody obtained in this study was not suitable for such analysis because of some crossreactivity with the zymogen form and also because of the low amounts of activated TGase 3 (data not shown). An approach using monoclonal antibody that speciˆcally recognizes the C-terminus of 47-kDa fragment might solve these problems. However, the anti-FGATS antibody will be useful to monitor the degree of proteolytic activation and to search for the activating proteases by Western blotting.
